Skip to main content
. 2018 Oct 11;42(6):3247–3255. doi: 10.3892/ijmm.2018.3929

Figure 2.

Figure 2

Evo inhibits NF-κB and MAPK pathways in vitro. Effects of Evo on the expression of proteins of the (A) NF-κB and (B) MAPK pathways in BEAS-2B cells infected with MSSA. Data are shown as the mean ± standard deviation. ##P<0.01, vs. control group; *P<0.05 and **P<0.01, vs. MSSA group. Evo, evodiamine; MSSA, methicillin-susceptible Staphylococcus aureus; NF-κB, nuclear factor-κB; MAPK, mitogen-activated protein kinase; IκB, inhibitor of NF-κB; JNK, c-Jun N-terminal kinase; Erk, extracellular signal-regulated kinase; p-, phosphorylated.